Sharemaestro Newsreel

The Economy Lost Jobs, Wall Street Threw a Party: What Moved Markets This Week

The American economy shed 23,000 nonfarm payrolls in July. Wall Street answered with its best week since April. That is not a contradiction. It turns on the fact that has defined 2026 and that many investors still find uncomfortable: the Federal Reserve's next move …

The Pennant Group Leverages Technology in Hospice Growth

The Pennant Group (Nasdaq: PNTG) is heavily investing in technology, particularly AI, to enhance its hospice and home health operations, improve quality, and boost revenue. The company is piloting AI tools to streamline clinical documentation and back-office processes, aiming to increase clinical capacity and …

Barclays Sticks to Its Hold Rating for Fresenius Medical Care AG & Co. KGaA (0H9X)

Barclays has maintained a Hold rating on Fresenius Medical Care AG & Co. KGaA (0H9X) with a price target of €44.50. This rating aligns with Goldman Sachs's Hold, while Jefferies reiterated a Sell rating on the company. Fresenius Medical Care currently has a market …

Here’s How Much You Would Have Made Owning Tenet Healthcare Stock In The Last 15 Years

Tenet Healthcare (NYSE: THC) has outperformed the market over the past 15 years with an average annual return of 18.6%. An initial investment of $100 in THC stock 15 years ago would now be worth $1,323.89, demonstrating the power of compounded returns. The company …

Earnings call transcript: Nutex Health tops Q2 2026 profit estimates

Nutex Health (NUTX) reported a significant profit beat in Q2 2026, with adjusted earnings of $9.38 per share against an estimate of $4.88, despite revenue slightly missing forecasts at $210.75 million. The company's shares rose over 10% as investors reacted positively to stronger margins, …

LifeStance Health Group, Inc. Q2 2026: Revenue $435.4M, EPS $0.06— 10-Q Summary

LifeStance Health Group, Inc. reported strong Q2 2026 results, with revenue increasing to $435.4M from $345.3M year-over-year, and net income turning profitable at $23.6M compared to a loss of $3.8M in Q2 2025. Diluted EPS reached $0.06, up from $(0.01) in the prior-year quarter. …

LifeStance Health Group, Inc. Stock 12‑Month Price Target Raised to $12.6, Implies 22% Upside

LifeStance Health Group, Inc.'s average price target has been increased from $12 to $12.6 by 10 analysts, suggesting a 22% potential upside from its Aug. 5 closing price. The consensus rating for the stock remains a "Buy" across 11 analysts, with 9 recommending Buy …

Oncology Institute Inc (TOI) Earnings Forecast: Future EPS & Revenue Growth Estimates

Encompass Health Beats Q2 Earnings Estimates, Raises '26 View

Universal Health Services Inc. Cl B stock outperforms competitors on strong trading day

Universal Health Services Inc. Cl B (UHS) stock advanced 2.25% to $173.54 on Friday, outperforming the broader market. The S&P 500 Index and Dow Jones Industrial Average also saw gains on the positive trading day. Despite the rise, the stock remains 29.55% short of …

Encompass Health (NYSE: EHC) grows Q2 2026 revenue and EPS

Encompass Health Corporation reported higher Q2 2026 results, with net operating revenues increasing to $1,597.4 million, driven by growth in patient discharges and net patient revenue per discharge. Net income attributable to Encompass Health was $153.9 million, and diluted EPS from continuing operations was …

The Joint Corp earnings beat by $0.02, revenue topped estimates

The Joint Corp (NASDAQ: JYNT) reported strong second-quarter results, surpassing analyst expectations with an EPS of $0.05 against an estimated $0.03. The company also exceeded revenue forecasts, bringing in $15.2M compared to the $14.57M consensus. Despite these positive earnings, the stock has seen declines …

Airsculpt Technologies Inc (AIRS) Stock News Today

Can agilon health (AGL) Justify Its Valuation As Earnings Turned Profitable?

Guardian Pharmacy Services (NYSE:GRDN) Stock Forecast & Analyst Predictions

Guardian Pharmacy Services (NYSE:GRDN) is projected to see annual earnings growth of 15.4% and revenue growth of 5.7%, with EPS expected to increase by 14.8%. Recent updates include beating analyst forecasts, raising full-year 2026 earnings guidance, and acquiring Wellness Concepts to expand its footprint. …

Addus HomeCare Corporation (NASDAQ:ADUS) Second-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year

Addus HomeCare Corporation recently released its Q2 results, prompting analysts to update their financial forecasts for the current fiscal year. The company's stock has seen a significant increase in price target from analysts, reflecting optimism about its future performance. Key changes in analyst expectations …

COMPASS Pathways plc SEC Filing (Aug 7, 2026)

This article reports on a Form 144 SEC filing by COMPASS Pathways plc (CMPS) dated August 7, 2026. The filing indicates a proposed sale of 83,771 American Depositary Shares, acquired through a stock option exercise on the same date, with an aggregate market value …

Guardian Pharmacy Services stock hits all-time high at 44.47 USD

Guardian Pharmacy Services Inc. has seen its stock reach an all-time high of $44.47, pushing its market capitalization to $2.5 billion. Despite a remarkable 118.93% increase in stock value over the past year, InvestingPro analysis suggests the stock might be overvalued relative to its …

AMN Healthcare Services (NYSE:AMN) Stock Price Up 16.5% Following Strong Earnings

Biote Corp (BTMD) Stock News Today

Brookdale Senior Living (BKD) Stock Looks Above Fair Value Following Its 239% Run

Concentra Group Holdings Parent (NYSE:CON) Reaches New 12-Month High After Earnings Beat

Concentra Group Holdings Parent (NYSE:CON) hit a new 52-week high after reporting better-than-expected quarterly earnings, with EPS of $0.52 against a $0.42 consensus and revenue of $606.03 million, up 10% year-over-year. Analysts remain largely positive, with seven rating the stock a "Buy" and one …

Guardian Pharmacy Services (NYSE:GRDN) Sets New 12-Month High After Better-Than-Expected Earnings

Kaplan Fox is Investigating The Ensign Group, Inc. (ENSG) for Potential Violations of the Federal Securities Laws

Kaplan Fox & Kilsheimer LLP is investigating The Ensign Group, Inc. (ENSG) for potential securities violations following a Hunterbrook Media report alleging inadequate patient care and data manipulation. The report, titled "Ensign: The Nursing Home Empire Built On Fatal Neglect," caused Ensign's stock to …

21,400 Shares in The Ensign Group, Inc. $ENSG Bought by Renaissance Technologies LLC

Renaissance Technologies LLC acquired a new stake of 21,400 shares in The Ensign Group, Inc. (ENSG) during the first quarter, valued at approximately $4.3 million. This purchase contributes to the 96.12% institutional ownership of ENSG, although some directors recently sold shares under pre-arranged plans. …

ENCOMPASS HEALTH CORP : TRUIST SECURITIES RAISES TARGET PRICE TO $150 FROM $140

Truist Securities has increased its target price for Encompass Health Corp (EHC.N) from $140 to $150. This adjustment signals a more optimistic outlook from the financial firm regarding the company's future stock performance.

Earnings call transcript: Concentra Q2 2026 profit, guidance raise lift shares 11%

Concentra Group Holdings Parent Inc. reported strong Q2 2026 results with a 10% increase in revenue to $606 million and adjusted EPS of $0.52, leading to an 11% surge in shares. The company also raised its full-year 2026 guidance for revenue, adjusted EBITDA, and …

Earnings To Watch: P3 Health Partners Inc (PIII) Q2 2026 -- GF Value Sees 48% Downside

DocGo Inc. (NASDAQ:DCGO) Receives Consensus Rating of "Hold" from Analysts

DocGo Inc. (NASDAQ:DCGO) has received a consensus "Hold" rating from six analysts, with an average 12-month price target of $2.375, significantly higher than its recent share price of $0.62. The company exceeded revenue expectations for its latest quarter, reporting $75.55 million against an estimated …

agilon health, inc. Stock 12‑Month Price Target Raised to $106.69, Implies 1% Downside

agilon health, inc.'s average stock price target has been raised from $85.92 to $106.69 by 13 analysts, with a range of $31 to $141 per share. This updated target suggests a 1% potential downside based on the August 5th closing price. The consensus rating …

Cross Country Healthcare Inc (CCRN) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Cross Country Healthcare Inc (CCRN), indicating a current earnings forecast score of 6.00 and an average price target of $11.00. It highlights expected revenue of $243.83M for the next quarter and an anticipated EPS of $0.01, following …

Concentra Group Holdings Parent, Inc. (CON) Stock Price, News, Quote & History

This Yahoo Finance page provides comprehensive information on Concentra Group Holdings Parent, Inc. (CON) stock, including its current price, historical data, financial overview, and analyst insights. The stock closed at $34.06 on August 7, 2026, up 11.53%, with significant year-to-date and one-year returns. The …

DaVita Shares Rise After TD Cowen Upgrades Stock to Buy

DaVita shares rose after TD Cowen upgraded the stock from Hold to Buy and increased its price target to $220. This upgrade was based on DaVita's strengthening competitive position, improving long-term growth prospects, and the potential impact of the MOTheR trial. The upgrade follows …

Truist Adjusts Price Target on DaVita to $215 From $250, Maintains Hold Rating

Truist has lowered its price target for DaVita (NYSE: DVA) to $215 from $250, while reiterating a "Hold" rating on the stock. This adjustment comes amidst other analyst actions on DaVita, with some firms raising and others adjusting their price targets, and follows DaVita's …

agilon health, inc. (AGL) stock price, news, quote and history

This page provides comprehensive information on agilon health, inc. (AGL) stock, including its current price, historical data, news, and financial analysis. It details key statistics like market cap, PE ratio, and earnings date, alongside performance comparisons with the S&P 500. The article also includes …

Janus Henderson Group PLC Raises Stock Position in DaVita Inc. $DVA

Janus Henderson Group PLC significantly increased its stake in DaVita Inc. by 96.2% during the first quarter, acquiring an additional 18,237 shares to total 37,188 shares valued at approximately $5.7 million. Other institutional investors also adjusted their positions, with institutional ownership now standing at …